US$ 87 million investments in optimizing HIV treatments
We find the best ideas and turn them into practical solutions for millions of people. Some examples:
Unitaid’s current main funders are France, the United Kingdom, Brazil, Norway, Chile, the Republic of Korea, Spain and the Bill & Melinda Gates Foundation.
For more information on Unitaid’s projects and partners, visit Unitaid’s website.
Countries have set ambitious global health targets for themselves. Goals we can only achieve by deeply transforming processes and systems, and by turning the most promising ideas into concrete solutions for millions of people in need. Unitaid’s initiatives are responding to some of the greatest challenges of our time, including Universal Health Coverage (UHC) and the fight against antimicrobial resistance – which could become one of the leading causes of death in the future if unaddressed. I would like to thank Ambassador Marta Maurás for her outstanding leadership at the helm of the Executive Board in the past year. Alongside our partners, we will continue making innovative, integrated solutions a reality for a stronger response.
Unitaid’s investments build highways for better health products to travel from the minds of innovators to people all over the world. But we cannot succeed in isolation. We collaborate with many types of partners—governments, industry, international and civil society organizations—to make sure innovations are quickly scaled up into life-changing solutions for everyone who needs them. Global health presents enormous challenges, and demands an intelligent and sustainable response from us. Each new investment takes us one step closer to fulfilling our collective vision of a fairer, healthier world.
A lifesaving emergency treatment for children with severe malaria, known as rectal artesunate, is prequalified by the World Health Organization (WHO). This enables procurement and distribution by international funders. The treatment is manufactured by Cipla Ltd. and supported by Unitaid and the Medicines for Malaria Venture.
READ MOREUnitaid seals a landmark deal with Cipla Ltd. to slash the price of Q-TIB, which prevents opportunistic infections in people living with HIV.
READ MOREUnitaid invests US$ 26 million in two projects led by the MTV Staying Alive Foundation and Solthis to further scale up HIV self-testing in Africa.
READ MOREUnitaid and the Asia Pacific Leaders Malaria Alliance (APLMA) launch a collaborative Vector Control Platform for Asia Pacific (VCAP). It brings together key actors in the region to accelerate access to innovations against malaria.
READ MOREUnitaid and a diverse group of partners jointly launch the MenStar Coalition, an effort to expand the diagnosis and treatment of HIV in men, particularly in sub-Saharan Africa.
READ MOREUnitaid moves to the Global Health Campus alongside the Global Fund, Gavi the Vaccine Alliance, the RBM Partnership to End Malaria and the Stop TB Partnership, strengthening its cooperation with key partners.
Unitaid and the Global Fund jointly invest US$ 66 million into the New Nets project, to be led by the Innovative Vector Control Consortium (IVCC).
READ MOREUnitaid is invited to speak at the United Nations General Assembly’s (UNGA) High-Level Meeting on tuberculosis, where it highlights the urgent need to speed up innovation to end TB.
READ MOREEleven heads of the world’s leading health and development organizations, including Unitaid, sign a landmark commitment to find new ways of working together to advance the UN Sustainable Development Goals (SDGs).
READ MOREUnitaid invests US$ 20 million to avert deaths from advanced HIV disease. The grant, to be implemented by Clinton Health Access Initiative (CHAI), is designed to make new tests and treatments affordable and available in lower-income countries.
READ MOREUnitaid invests US$ 1.5 million to stimulate HIV self-testing in Kenya in partnership with the Elton John Foundation and the Children’s Investment Fund Foundation (CIFF).
READ MOREThe United Kingdom provides an additional £27 million to Unitaid to invest in malaria control, building upon its existing investment as a founding member of Unitaid.
Unitaid invests US$ 59 million in two innovative projects to corner malaria-carrying mosquitoes. These projects will be led by the University of Notre Dame and the Barcelona Institute for Global Health (ISGlobal).
READ MOREUnitaid is investing US$ 33 million to speed up access to screen-and-treat solutions for as little as US$ 1. The initiative, to be led by CHAI, will deploy artificial intelligence-based screening tools and will introduce new portable devices for treatment of precancerous cervical lesions.
READ MORE